Clinical implications of molecular neuropathology and biomarkers for malignant glioma. - Wikidata - awgldk - TriplyDB

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

http://www.wikidata.org/entity/Q37994631

about

Epidemiologic and molecular prognostic review of glioblastoma Retinoids in the treatment of glioma: a new perspective.How molecular testing can help (and hurt) in the workup of gliomas.What do we know about IDH1/2 mutations so far, and how do we use it?TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma.Canine brain tumours: a model for the human disease?Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.Increased expression of microRNA-17 predicts poor prognosis in human glioma.Overexpression of MACC1 protein and its clinical implications in patients with glioma.Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients.

P2860

Q28395302-9FF2041F-B4DD-48CA-9309-DFF1287DA7C0 Q30464615-DCDF8CDF-F2ED-436E-BD68-24AD7F5EC320 Q35770275-13FF38F8-1089-4479-9BD8-FA3492860E3E Q36788229-1C64FD20-D107-40F8-928F-AAE16F597D49 Q37187694-B7E93306-2B3D-4F52-9BDA-20E0464FDCB6 Q37379251-8CD8E85B-E01C-4641-BF1A-EF496924B85C Q38491009-D40BD41C-64C2-43C4-80B3-19132D447BE2 Q38710161-A01F5EFF-9E5E-41A1-9246-F78AD28E69A9 Q41808943-A8F1A582-5670-4413-A2A6-BF00A2F3BDE4 Q45991279-2EA86767-8252-4F71-BE44-ABD384A1118A Q47094808-B5FEFE1C-5A83-45AC-A845-3BCC0E6A5FBB Q48797026-671450F8-98FE-4AFA-B3AF-2ED210826BCF

P2860

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

http://www.wikidata.org/entity/Q37994631

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@en

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@nl

type

label

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@en

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@nl

prefLabel

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@en

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@nl

P1433

Q37994631-C32695F4-CE05-4452-A23B-4FCB6762FC0D

P1476

Q37994631-3D1F4948-CE70-443C-9624-DDCAEF8518C0

P2093

Q37994631-52D3BB76-8741-4976-9427-846CC7C72AA3

Q37994631-C98A4AE7-3919-4FD8-BCFA-DCA5E4547828

P2860

Q37994631-0F9A820C-5C33-4CC9-BAA0-7B28AA88F04C

Q37994631-13089625-410C-4DC5-9948-80DF47B7BE70

Q37994631-18A221DF-9D53-4FF8-AC0A-C31A7B097C42

Q37994631-1A664ACD-62F4-4E64-B471-AA4073F02BC7

Q37994631-1D799A05-0F21-414E-9875-CB76E9A45EBD

Q37994631-2243D4DF-1302-41F1-B5D1-23883F9F49CD

Q37994631-243EC3E3-F637-42E7-AD9A-D04B800EAB90

Q37994631-3DFF4524-F0EA-466C-B7DE-D7FEEF49627A

Q37994631-4A7A74A0-599A-4CFF-AE37-EFDC54AE4744

Q37994631-4F141641-11F7-48BE-80B2-3D032130AE46

P2888

Q37994631-2D997A37-9430-444D-BEBC-5062CD893E20

P304

Q37994631-5A505643-053B-43FE-8D87-941D28DE736E

P31

Q37994631-770130FA-6C25-405B-B110-A1C697450DAC

P356

Q37994631-EF12E961-F72F-43BB-8B66-A866D3636C33

P433

Q37994631-03F2713E-D091-425E-9D34-999F92F07AE7

P478

Q37994631-B0F5F859-7FDA-439F-AC45-7366F4637517

P50

Q37994631-755536BB-A8FB-4EFE-BCC5-FA3435743094

Q37994631-D30CE125-FB75-4880-B88C-4A66CD1D64A6

P577

Q37994631-72C41B98-4071-485C-A939-4EFB59CECF59

P698

Q37994631-5223673D-BD45-4C6E-B628-B6DF37FB1409

P921

Q37994631-2B5C4F38-1BCC-4034-8031-04A986DD3491

P356

S11910-012-0263-X

P1433

Current Neurology and Neuroscience Reports

P1476

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

@en

P2093

Monika Hegi

http://www.w3.org/2001/XMLSchema#string

Roger Stupp

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

The 2007 WHO classification of tumours of the central nervous system

MGMT gene silencing and benefit from temozolomide in glioblastoma.

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

P2888

s11910-012-0263-x

P304

302-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-012-0263-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ghazaleh Tabatabai

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22427102

http://www.w3.org/2001/XMLSchema#string

P921